ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PAOG PAO Group Inc (PK)

0.0006
0.0002 (50.00%)
Last Updated: 17:00:29
Delayed by 15 minutes
Share Name Share Symbol Market Type
PAO Group Inc (PK) USOTC:PAOG OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0002 50.00% 0.0006 0.0004 0.0006 0.0006 0.0004 0.0004 500,500 17:00:29

PURA Announces Sale Of Cannabis Cultivation Operation With Shareholder Dividend

28/07/2020 8:08pm

InvestorsHub NewsWire


Dallas, TX -- July 28, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today announced the sale of its cannabis cultivation operation to PAO Group, Inc. (USOTC: PAOG).  The operation was sold for a $1,000,000 valuation.  The cannabis cultivation operation was sold in exchange for PAOG common stock.  The stock is slated to be distributed to PURA shareholders in a dividend distribution.  The planned distribution ratio is 1 for 1.  Accordingly, PURA shareholders will receive one share of PAOG stock in exchange for every PURA share held.  PURA plans to issue more details next week on the planned dividend distribution.

For more information on Puration, visit https://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley,

info@aciconglomerated.com
(800) 861-1350


 

1 Year PAO (PK) Chart

1 Year PAO (PK) Chart

1 Month PAO (PK) Chart

1 Month PAO (PK) Chart